IDNA Among Health Care ETFs
End-of-day Nov 20, 2026 · 32 Health care ETFs by 1Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.1% | −7.7% | −9.8% | −6.7% | +41.9% | +44.1% | +95.6% | −19.3% | — | +59.6% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$130 of every $1,000 in IDNA is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 13.00% | $1,300.09 | 209K | $41.6M |
| 2 | GMAB.COGenmab | Healthcare | 6.45% | $645.20 | 40K | $20.7M |
| 3 | TWSTTwist Bioscience | Healthcare | 4.99% | $498.94 | 143K | $16.0M |
| 4 | REGNRegeneron Pharmaceuticals | Healthcare | 4.50% | $449.53 | 16K | $14.4M |
| 5 | BAYN.DEBayer AG | Healthcare | 4.45% | $444.83 | 237K | $14.2M |
| 6 | 4502.TTakeda Pharmaceutical | Healthcare | 4.37% | $437.14 | 322K | $14.0M |
| 7 | EXELExelixis | Healthcare | 3.86% | $386.31 | 188K | $12.4M |
| 8 | VRTXVertex Pharmaceuticals | Healthcare | 3.61% | $360.61 | 22K | $11.6M |
| 9 | ROP.SWRoche PS PAR AG | Healthcare | 3.56% | $355.79 | 24K | $11.4M |
| 10 | INCYIncyte | Healthcare | 3.50% | $349.92 | 97K | $11.2M |
| 11 | MRKMerck | Healthcare | 3.40% | $340.34 | 82K | $10.9M |
| 12 | RVMDRevolution Medicines | Healthcare | 3.31% | $330.59 | 66K | $10.6M |
| 13 | SAN.PASanofi | Healthcare | 3.16% | $316.29 | 110K | $10.1M |
| 14 | IPN.PAIpsen | Healthcare | 3.03% | $302.73 | 54K | $9.7M |
| 15 | GSK.LGlaxosmithkline | Healthcare | 2.86% | $286.16 | 382K | $9.2M |
of the $108B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 13.00% |
| 2 | GMAB.CO | Genmab | 6.45% |
| 3 | TWST | Twist Bioscience | 4.99% |
| 4 | REGN | Regeneron Pharmaceuticals | 4.50% |
| 5 | BAYN.DE | Bayer AG | 4.45% |
| 6 | 4502.T | Takeda Pharmaceutical | 4.37% |
| 7 | EXEL | Exelixis | 3.86% |
| 8 | VRTX | Vertex Pharmaceuticals | 3.61% |
| 9 | ROP.SW | Roche PS PAR AG | 3.56% |
| 10 | INCY | Incyte | 3.50% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 15, 2026 | Jun 18, 2026 | $0.13 |
| Dec 16, 2025 | Dec 19, 2025 | $0.16 |
| Jun 16, 2025 | Jun 20, 2025 | $0.15 |
| Dec 17, 2024 | Dec 20, 2024 | $0.11 |
| Jun 11, 2024 | Jun 17, 2024 | $0.11 |
| Dec 20, 2023 | Dec 27, 2023 | $0.17 |
| Jun 7, 2023 | Jun 13, 2023 | $0.0708 |
| Jun 9, 2022 | Jun 15, 2022 | $0.14 |
| Dec 13, 2021 | Dec 17, 2021 | $0.26 |
| Jun 10, 2021 | Jun 16, 2021 | $0.0520 |
| Dec 14, 2020 | Dec 18, 2020 | $0.0362 |
| Jun 15, 2020 | Jun 19, 2020 | $0.0837 |